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1. Introduction
Primary retroperitoneal mucinous tumors (PRMTs) are a group of
rare neoplasms that consist of three subtypes: mucinous cystadenomas,
mucinous borderline tumors or tumors of low malignant potential, and
mucinous carcinoma. While the pathogenesis remains unclearly defined,
PRMTs are believed to arise from mucinous metaplasia of invaginated
mesothelium into the retroperitoneum. These rare tumors largely
resemble their ovarian counterparts; however, they lack evidence of
ovarian tissue upon pathologic review. Establishing a diagnosis of
PRMTs preoperatively is challenging, as diagnosis largely occurs in the
postoperative setting. Herein, we report the case of a 60-year-old female
who presented with abdominal distention, pelvic pain, and bloating
with a newly discovered 18 cm retroperitoneal cystic lesion on cross
sectional imaging. Pathological findings confirmed a mucinous border
line tumor of Müllerian origin after surgical resection.
2. Case presentation
A 60-year-old Indonesian-speaking female presented for evaluation
of a left-sided abdominal mass detected during physical exam by her
primary care provider, coincident with a recent history of abdominal
distension, non-specific pelvic pain that radiated to her groins bilaterally
with post-prandial bloating. She denied changes in her bowel move
ments, fevers, fatigue or significant weight loss. Past medical history was
non-contributory without a prior surgical history. With suspicion of an
abdominal mass on physical exam, a CT scan revealed an 11 cm × 14 cm
× 18 cm, well-defined ovoid fluid density in her left lower abdomen/
retroperitoneum (Fig. 1). A preoperative colonoscopy demonstrated no
synchronous disease-related pathology. With concern for underlying
malignancy, the patient proceeded to surgical resection.
Exploratory
laparotomy
revealed
a
well
encapsulated,

circumscribed, cystic-appearing lesion emanating from the left retro
peritoneum just medial to the left psoas musculature involving but not
infiltrating into mesentery of the rectosigmoid. There was no further
gross pathology identified in the abdomen or pelvis, including the
adnexa, uterus, ovaries, appendix, as well as small and large bowel; all
not requiring resection. Surgical resection was limited to the mass,
including closely associated peritoneum and mesentery. En bloc resec
tion of bowel was not required, as the lesion appeared in situ, grossly
non-infiltrating, and amenable to mesenteric/bowel sparing surgery.
Gross examination revealed a large 18 cm cystic mass with a smooth
outer surface. Further inspection revealed a unilocular cyst containing
brown watery fluid and cyst wall with mostly smooth inner lining and a
focally raised papillary region. Microscopically, the cyst lining showed
atypical epithelial proliferation with architectural complexity, including
tufting and villous or papillary formation in thickened regions (Fig. 2).
The tumor was composed of mucinous gastrointestinal-type epithelium
with mild to moderate cytologic atypia, nuclear crowding or stratifica
tion, and goblet cells. There was no evidence of invasion into sur
rounding dense fibrous stroma. No ovarian tissue was identified.
Immunohistochemical stains showed tumor cells positive for CK7
(strong, diffuse), PAX8 (patchy), and CK20 (focal), and negative for
CDX2 and SATB2. Pathological findings supported a diagnosis of a
mucinous borderline tumor of Müllerian origin. Postoperative course
was uneventful and the patient discharged on the second postoperative
day. Follow-up imaging of the abdomen and pelvis seven months post
operatively remains without evidence of disease recurrence (Fig. 1).
3. Discussion
Primary retroperitoneal mucinous tumors (PRMTs) are a group of
rare neoplasms that consist of three subtypes: mucinous cystadenomas,
mucinous borderline tumors of low malignant potential, and mucinous
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Fig. 1. A-B Contrast-enhanced preoperative CT scan of the 18 cm fluid-filled cystic mass in the left abdomen (A coronal, B axial) concerning for potential malig
nancy. C-D Contrast-enhanced CT scan 7 months postoperatively demonstrating no evidence of recurrent disease (A coronal, B axial).

carcinoma. To our knowledge, there are approximately 150 cases re
ported in the world literature, to date. PRMTs are typically asymptom
atic with clinical manifestations arising as they enlarge, with the most
common symptoms related to mass effect including abdominal disten
tion and pain (Myriokefalitaki et al., 2016). Vastly occurring in women,
PRMTs presenting in males are rarely described (Thamboo et al., 2006;
Benkirane et al., 2009).
Herein, we discuss the case of a 60-year-old female who presented
with several months of abdominal distension, post-prandial bloating,
and pelvic pain, later found to have a large cystic mass on imaging and
subsequently underwent surgical resection (Fig. 1). Histopathologic
evaluation confirmed the presence of a mucinous neoplasm that was
morphologically and phenotypically Müllerian in origin, staining posi
tive for CK7 and PAX8 on immunohistochemistry; however, lacking
pathologic evidence of true ovarian tissue (Fig. 2). Notably, the patient
had grossly normal ovaries and adnexa during the time of surgery.
Importantly, features of malignancy including marked cytologic atypia,
confluent or solid tumor growth, and stromal invasion were absent.
Histologically, these tumors resemble ovarian mucinous neoplasms;
however, lack of true ovarian tissue is requisite for pathologic confir
mation (Bifulco et al., 2008; Subramony et al., 2001). Indeed, the origin
of these tumors is largely unknown, with three theories of pathogenesis
predominating. One theory proposes that these tumors arise from a
teratoma with overgrowth of the mucinous component, while another
favors a neoplasm originating from heterotopic ovarian tissue (Acharya
et al., 2016; Paraskevakou et al., 2014; Roma and Malpica, 2009). This

latter etiology holds less favor as most reports note an absence of asso
ciated ovarian stroma. The most widely supported etiology favors
mucinous metaplasia of the overlying peritoneal mesothelium with
resultant cystic mass formation (Subramony et al., 2001; Tenti et al.,
1994; Isse et al., 2004). This is based on precedent that peritoneal
mesothelium has potential for Müllerian differentiation. Another pos
sibility is that these tumors may originate from remnants of the
embryonal urogenital apparatus.
Confirming diagnosis of these tumors preoperatively is challenging
with the rarity of presentation and lack of objective radiographic criteria
and diagnostic surrogates. Notably, fine needle aspiration of PRMTs and
evaluation of aspirated fluid typically provides a paucity of diagnostic
information (Cabello Benavente et al., 2017). Consequently, definitive
diagnosis requires surgical resection. At our institution, multidisci
plinary consensus remains that if an abdominal mass (solid or cystic) is
concerning for premalignancy and/or potentially harbors a cancer, and
patient performance status and mass appear amenable to complete
surgical removal with curative intent, we typically advocate for upfront
resection without preoperative biopsy. A preoperative biopsy of a large
cystic lesion without solid components is not recommended. This is
particularly relevant in our patient with a symptomatic resectable cystic
mass. Importantly, this approach obviates potential biopsy-related risks
for spillage and/or iatrogenic tumor cell dissemination. Indeed, PRMT is
a diagnosis of exclusion, with more frequently encountered epithelial
tumors located in the retroperitoneum including ovarian, gastrointes
tinal, renal cancers and advanced disease metastases. In cases when a
2
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Fig. 2. A. Thickened areas of cyst wall with papillary proliferation (H&E, x20). B. Columnar cells with intracellular mucin, occasional goblet cells, nuclear strat
ification, mild to moderate atypia (H&E, x200). C-D. Immunohistochemistry for CK7 (C) and PAX8 (D).

rare, mucin–containing neoplasm is encountered, potential for syn
chronous colorectal malignancies can occur which necessitates surveil
lance colonoscopy in appropriate female at-risk patients (Morano et al.,
2018).
In general, patients with resectable retroperitoneal masses concern
ing for malignancy are candidates for surgery with curative intent.
Operative treatment includes open and/or minimally invasive strategies
that permit careful, safe resection and simultaneous inspection for
synchronous disease (Cabello Benavente et al., 2017; Foula et al., 2019).
Importantly, cystic fluid has potential to harbor malignant cells, thus
surgeons must take extreme care to avoid iatrogenic rupture of the mass
during resection. Postoperative treatment considerations are contingent
upon pathological review. In our case, this patient with a borderline
mucinous tumor underwent surgical resection followed by multidisci
plinary recommendation for annual surveillance imaging, thereafter.
Currently, there are no consensus guidelines regarding postsurgical
follow-up and surveillance for PRMTs; long-term prognosis for patients
with mucinous cystadenomas and mucinous borderline tumors remains
favorable, with a 5-year survival reportedly nearing 100% (Wolf et al.,
2017). Adjuvant therapy is rarely indicated for borderline tumors
(Dayan et al., 2016). In contrast, patients with a diagnosis of mucinous
cystadenocarcinoma with reported 5-year survival of 68% necessitates
important considerations and strategies for adjuvant therapy (Wolf
et al., 2017). Notably, treatment approaches that include hysterectomy,
salpingo-oophorectomy, and adjuvant systemic therapy have yet to yield
demonstrable survival benefit for this biologically aggressive variant of
PRMT.

after surgical resection. We highlight the importance for consideration
of primary retroperitoneal mucinous tumors (PRMTs) in the differential
diagnosis when encountering retroperitoneal cystic lesions. Surgical
resection provides durable disease control for mucinous borderline tu
mors or tumors of low malignant potential, as seen in our patient and
reported in the existing literature. Limitations of this case report include
the retrospective nature of this review, duration of follow-up, and
requirement for more conclusive, larger patient outcome studies to
validate this treatment strategy.
5. Consent
Written consent was obtained from the patient for publication of this
case report.
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